LONDONÂ and NEW YORK
 , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders.
Credit:
Share
The governments of Taiwan and Palau have been operating a “travel bubble” since April 1, marking the return of international tourism between the two islands.
Both countries have managed the pandemic exceptionally well, but travel between the two hasn’t come roaring back just yet. Barriers like airline prices and health restrictions make traveling in the pandemic more difficult, and demand for trips is low.
Since the beginning of the pandemic, Taiwan has reported just over 1,100 cases total, and Palau has reported 0 cases. On April 1, Palau one of Taiwan’s few official diplomatic allies opened a “sterile corridor” to allow tourists to visit without quarantining upon arrival.
Anomalously warm weather and acute care visits in patients with multiple sclerosis: A retrospective study of privately insured individuals in the US plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.